J M Ahearn|D T Fearon - JoVE Visualize

Showing results (101-110 of 154) with videos related to

Pageof 16

Sort By:

Journal of Virology|May 1, 1993

Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21)D C Montefiori, K Stewart, J M Ahearn, et al.

Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2001

The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cellsJ S Navratil, S C Watkins, J J Wisnieski, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 1, 1985

A unique structure at the carboxyl terminus of the largest subunit of eukaryotic RNA polymerase IIJ L Corden, D L Cadena, J M Ahearn, et al.

Science (New York, N.Y.)|January 19, 1996

C3d of complement as a molecular adjuvant: bridging innate and acquired immunityP W Dempsey, M E Allison, S Akkaraju, et al.

Complement (Basel, Switzerland)|January 1, 1986

Decreased expression of C3b receptor (CR1) on erythrocytes of patients with systemic lupus erythematosus contrasts with its normal expression in other systemic diseases and does not correlate with the occurrence or severity of SLE nephritisM H Jouvin, J G Wilson, P Bourgeois, et al.

The Journal of Experimental Medicine|January 1, 1996

A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitorsA Rolink, E ten Boekel, F Melchers, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1984

Inhibition of the function of activated properdin by squid chondroitin sulfate E glycosaminoglycan and murine bone marrow-derived mast cell chondroitin sulfate E proteoglycanJ G Wilson, D T Fearon, R L Stevens, et al.

Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1988

Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytesR H Carter, M O Spycher, Y C Ng, et al.

Surgery|September 1, 1987

Neutrophil activation after burn injury: contributions of the classic complement pathway and of endotoxinC F Davis, F D Moore, M L Rodrick, et al.

The Journal of Experimental Medicine|March 28, 1998

Inhibition of the B cell by CD22: a requirement for LynK G Smith, D M Tarlinton, G M Doody, et al.

Pageof 16

Showing results (101-110 of 154) with videos related to

Sort By:

Pageof 16

Journal of Virology|May 1, 1993

Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21)D C Montefiori, K Stewart, J M Ahearn, et al.

Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2001

The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cellsJ S Navratil, S C Watkins, J J Wisnieski, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 1, 1985

A unique structure at the carboxyl terminus of the largest subunit of eukaryotic RNA polymerase IIJ L Corden, D L Cadena, J M Ahearn, et al.

Science (New York, N.Y.)|January 19, 1996

C3d of complement as a molecular adjuvant: bridging innate and acquired immunityP W Dempsey, M E Allison, S Akkaraju, et al.

Complement (Basel, Switzerland)|January 1, 1986

Decreased expression of C3b receptor (CR1) on erythrocytes of patients with systemic lupus erythematosus contrasts with its normal expression in other systemic diseases and does not correlate with the occurrence or severity of SLE nephritisM H Jouvin, J G Wilson, P Bourgeois, et al.

The Journal of Experimental Medicine|January 1, 1996

A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitorsA Rolink, E ten Boekel, F Melchers, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1984

Inhibition of the function of activated properdin by squid chondroitin sulfate E glycosaminoglycan and murine bone marrow-derived mast cell chondroitin sulfate E proteoglycanJ G Wilson, D T Fearon, R L Stevens, et al.

Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1988

Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytesR H Carter, M O Spycher, Y C Ng, et al.

Surgery|September 1, 1987

Neutrophil activation after burn injury: contributions of the classic complement pathway and of endotoxinC F Davis, F D Moore, M L Rodrick, et al.

The Journal of Experimental Medicine|March 28, 1998

Inhibition of the B cell by CD22: a requirement for LynK G Smith, D M Tarlinton, G M Doody, et al.

Pageof 16